Get the latest news, insights, and market updates on HCAT (Health Catalyst, Inc.). Explore the news page 3 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
3 of Wall Street’s Favorite Stocks We Think Twice About
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts. Dec 16, 2025 - $HCAT
Matt Arens, CEO and Founder of Health Catalyst's Largest Shareholder, First Light Asset Management, Joins Board of Directors
Health Catalyst, Inc. ("Health Catalyst" or the "Company," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Matt Arens, CEO and Founder of First Light Asset Management, LLC ("First Light"), has been appointed to serve as a member of Health Catalyst's board of directors ("Board"), effective Dec. 1, 2025. Dec 2, 2025 - $HCAT
Health Catalyst and Unity Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after renewed enthusiasm for Alphabet reinvigorated the artificial intelligence trade, propelling a market rebound heading into the Thanksgiving holiday. The Nasdaq index jumped 2.6% and the S&P 500 gained 1.6%, driven by a 5% rally in Alphabet following the announcement of its upgraded Gemini 3 AI model. This optimism spilled over into the broader tech sector, lifting shares of Broadcom, Micron, and Palantir significantly. The rally built on mo Nov 24, 2025 - $HCAT
Health Catalyst (HCAT): Buy, Sell, or Hold Post Q3 Earnings?
What a brutal six months it’s been for Health Catalyst. The stock has dropped 44.2% and now trades at $2.18, rattling many shareholders. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation. Nov 19, 2025 - $HCAT
5 Revealing Analyst Questions From Health Catalyst’s Q3 Earnings Call
Health Catalyst’s third quarter results were met with a positive market reaction as the company delivered revenue above Wall Street expectations despite flat year-over-year performance. Management attributed the quarter’s outcome to solid execution in the Technology segment, which saw continued demand for its applications, and progress in improving gross margins through cost controls and operational changes. CEO Dan Burton highlighted that new client additions and successful client case studies, Nov 17, 2025 - $HCAT
Why Analysts Say the Health Catalyst Story Is Shifting With New Guidance and Growth Challenges
Health Catalyst has experienced a notable reduction in its Fair Value Estimate, dropping from $4.56 to $3.94. Analysts have updated their views in response to shifting business trends. The Discount Rate has also moved higher, rising from 9.63% to 10.54%, which illustrates increased perceived risk surrounding the company’s future outlook. As the narrative for Health Catalyst stock continues to evolve, readers should follow ongoing coverage to better navigate the shifting landscape and stay... Nov 14, 2025 - $HCAT
Health Catalyst to Participate in Upcoming Investor Conferences
SALT LAKE CITY, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that members of senior management will participate in the following upcoming investor conferences: The Stephens Annual Investment Conference, being held in Nashville, including a fireside chat with Ben Albert, President and Chief Operating Officer, Jason Alger, Chief Financial Offic Nov 14, 2025 - $HCAT
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" to help us understand site usage and improve the platform.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.